| Measure Title: | RELATING TO GENETIC ENGINEERING. |
| Report Title: | Genetic Engineering; Disclosure |
| Description: | Requires a biotech company that sells a genetically engineered organism to provide written disclose of possible risks from the use of such an organism; written notice does not waive any liability a biotech company may have toward a purchaser. |
| Package: | None |
| Companion: | |
| Introducer(s): | ENGLISH (BR) |
| Current Referral: | WLA/EIA, JHW |
| Date | Status Text | |
|---|---|---|
| 1/24/2005 | S | Introduced. |
| 1/26/2005 | S | Passed First Reading. |
| 1/31/2005 | S | Referred to WLA/EIA, JHW. |
| 2/3/2005 | S | The committee on WLA/EIA has scheduled a public hearing on 02-10-05 at 1:15 pm in conference room 224. |
| 2/10/2005 | S | The committees on EIA and WLA deferred the measure. |
| 12/2/2005 10:32:44 AM | D | Carried over to 2006 Regular Session. |
$ = Appropriation measure
ConAm = Constitutional Amendment